Healthcare stocks in India fell on Friday as investors weighed the impact of U.S. President Donald Trump’s move to impose a 100% tariff on branded and patented drugs starting Oct. 1. The measure, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback